Arvind Kush

Insider Reports History

Location
San Diego, CA
Signature
/s/ David McIntyre, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Arvind Kush:

Company Role Class Num Shares Value Price $ Report Date Ownership
Inhibikase Therapeutics, Inc. Director Common Stock 145,000 $198,650 $1.37 21 Oct 2024 Direct
RayzeBio, Inc. CHIEF FINANCIAL OFFICER Common Stock 0 $0 $62.50 26 Feb 2024 Direct
Inhibikase Therapeutics, Inc. Director Stock Option (Right to Buy) 108,176 30 Jun 2025 Direct
RayzeBio, Inc. CHIEF FINANCIAL OFFICER Employee Stock Option (right to buy) 0 26 Feb 2024 Direct

Insider Reports Filed by Arvind Kush

Symbol Company Period Transactions Value $ Form Type Role Filing Time
IKT Inhibikase Therapeutics, Inc. 30 Jun 2025 1 $0 4 Director 02 Jul 2025, 19:41
IKT Inhibikase Therapeutics, Inc. 14 Feb 2025 2 $0 4 Director 19 Feb 2025, 20:19
IKT Inhibikase Therapeutics, Inc. 21 Oct 2024 2 +$198,650 4 Director 23 Oct 2024, 19:49
IKT Inhibikase Therapeutics, Inc. 21 Oct 2024 0 $0 3 Director 23 Oct 2024, 19:40
RYZB RayzeBio, Inc. 26 Feb 2024 4 -$4,902,062 4 CHIEF FINANCIAL OFFICER 27 Feb 2024, 16:42
RYZB RayzeBio, Inc. 17 Nov 2023 1 $0 4 Chief Financial Officer 17 Nov 2023, 18:38
RYZB RayzeBio, Inc. 14 Sep 2023 0 $0 3 Chief Financial Officer 14 Sep 2023, 20:39